Development of a catheter-based technique for endoluminal radiofrequency sealing of pancreatic duct by Ewertowska, Elzbieta et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=ihyt20
International Journal of Hyperthermia
ISSN: 0265-6736 (Print) 1464-5157 (Online) Journal homepage: https://www.tandfonline.com/loi/ihyt20
Development of a catheter-based technique for
endoluminal radiofrequency sealing of pancreatic
duct
Elżbieta Ewertowska, Anna Andaluz, Xavier Moll, Adrià Aguilar, Felix Garcia,
Dolors Fondevila, Rita Quesada, Macarena Trujillo, Fernando Burdío &
Enrique Berjano
To cite this article: Elżbieta Ewertowska, Anna Andaluz, Xavier Moll, Adrià Aguilar, Felix Garcia,
Dolors Fondevila, Rita Quesada, Macarena Trujillo, Fernando Burdío & Enrique Berjano (2019)
Development of a catheter-based technique for endoluminal radiofrequency sealing of pancreatic
duct, International Journal of Hyperthermia, 36:1, 677-686, DOI: 10.1080/02656736.2019.1627585
To link to this article:  https://doi.org/10.1080/02656736.2019.1627585
© 2019 The Author(s). Published with
license by Taylor & Francis Group, LLC
Published online: 18 Jul 2019.
Submit your article to this journal 
Article views: 11
View Crossmark data
Development of a catheter-based technique for endoluminal radiofrequency
sealing of pancreatic duct
El_zbieta Ewertowskaa, Anna Andaluzb, Xavier Mollb, Adria Aguilarb, Felix Garciab, Dolors Fondevilab ,
Rita Quesadac , Macarena Trujillod , Fernando Burdıoe and Enrique Berjanoa
aBioMIT, Department of Electronic Engineering, Universitat Politecnica de Valencia, Valencia, Spain; bDepartament de Medicina i Cirurgia
Animals, Facultat de Veterinaria, Universitat Autonoma de Barcelona, Barcelona, Spain; cDepartment of Experimental and Health Sciences,
Universitat Pompeu Fabra, Barcelona, Spain; dBioMIT, Department of Applied Mathematics, Universitat Politecnica de Valencia, Valencia,
Spain; eDepartment of Surgery, Hospital del Mar, Barcelona, Spain
ABSTRACT
Introduction: Endoluminal sealing of the pancreatic duct by glue or sutures facilitates the manage-
ment of the pancreatic stump. Our objective was to develop a catheter-based alternative for endolu-
minal radiofrequency (RF) sealing of the pancreatic duct.
Materials and methods: We devised a novel RF ablation technique based on impedance-guided cath-
eter pullback. First, bench tests were performed on ex vivo models to tune up the technique before
the in vivo study, after which endoluminal RF sealing of a 10 cm non-transected pancreatic duct was
conducted on porcine models using a 3 Fr catheter. After 30 days, sealing effectiveness was assessed
by a permeability test and a histological analysis.
Results: The RF technique was feasible in all cases and delivered 5W of power on an initial imped-
ance of 308±60X. Electrical impedance evolution was similar in all cases and provided guidance for
modulating the pullback speed to avoid tissue sticking and achieve a continuous lesion. During the
follow-up the animals rate of weight gain was significantly reduced (p< 0.05). Apart from signs of exo-
crine atrophy, no other postoperative complications were found. At necropsy, the permeability test
failed and the catheter could not be reintroduced endoluminally, confirming that sealing had been
successful. The histological analysis revealed a homogeneous exocrine atrophy along the ablated seg-
ment in all the animals.
Conclusions: Catheter-based RF ablation could be used effectively and safely for endoluminal sealing
of the pancreatic duct. The findings suggest that a fully continuous lesion may not be required to
obtain complete exocrine atrophy.
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1. Introduction
Sealing of the pancreatic duct is used to manage two main
pancreatic malignancies: pancreatitis and pancreatic ductal
adenocarcinoma [1]. Sealing is usually achieved either by
ligation of the affected pancreatic duct to eliminate pancre-
atic secretions or tumor resection followed by anastomosis
of the remaining pancreatic stump [2,3]. However, the com-
mon problem of leakage of the pancreatic contents into the
abdomen, also known as pancreatic fistula, can affect patient
morbidity and mortality during the postoperative period.
Many studies have explored feasible techniques for sealing
the pancreatic stump in order to replace anastomosis and
minimize the risk of leakage [4]. Sutures, staplers, clips or
endoluminal glue injections are some of the most frequently
used tools currently used in clinical practice. However, none
of these techniques has been proven to effectively reduce
the high risk of failure in these cases.
Radiofrequency ablation (RFA) is one of the recently
explored sealing techniques. In this case the action mechan-
ism does not rely on introducing a sealing agent, but on
inducing epithelial necrosis to trigger fibrosis (cicatrization)
and collagen shrinkage and cause ductal atrophy. Our
research group had already examined the effect of pancre-
atic stump closure by RF-assisted transection in terms of fis-
tula formation on rat and pig models [5–7]. The results
showed that RFA not only induced exocrine atrophy for duc-
tal occlusion but also reduced the occurrence of fistula.
These findings encouraged us to go beyond the transection
plane and consider extending RFA endoluminally along a
segment of the pancreatic duct itself.
The concept of endoluminal thermal ablation is not really
new since it has already been used in clinical applications for
vascular occlusion such as e.g. hepatic tumor arteries, vari-
cose veins [8,9] and biliary tumors [10]. However, to our
knowledge, there is no evidence that this technique has
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been previously employed for pancreatic remnant sealing, as
proposed here. As in the case of glue, the main purpose of
thermal coagulation of the duct walls is to prevent leakage
by sealing the secretory ducts along its walls and inducing
ductal atrophy and also ensure the loss of ductal permeabil-
ity. In order to efficiently perform endoluminal ablation of
the pancreas, a thermal coagulation zone should meet the
following characteristics: (1) it should be long enough to suit
the remnant pancreas after a resection; (2) be as contiguous
as possible, i.e. with the minimum number and length of
gaps; (3) there should be sufficient margin across the duct
wall, i.e. ablate the entire epithelium and ensure loss of per-
meability, which requires a depth of 1–2mm; and (4) it must
be safe, i.e. no steam pops or tissue disruption, which means
keeping tissue temperature below 80–90 C and avoiding tis-
sue sticking to the electrode.
Additional technical requirements for a device aimed at
endoluminal surgery of the pancreatic duct should also
include: (1) a suitable diameter to fit the duct along the
entire route; (2) flexible enough to pass easily through the
duct, which is not usually straight; and (3) be long enough
to cover the entire target segment. The electrodes used to
create the thermal lesion should be on the catheter itself. In
this context, our objective was thus to develop a new cath-
eter-based technique for endoluminal RF sealing of the pan-
creatic duct and to assess its safety and performance on an
in vivo porcine model.
2. Materials and methods
The first phase, based on an ex vivo model, was used to tune
up the experimental setup, which consisted of an RF catheter
combined with impedance-guided pullback. The aim was to
determine the suitability of the catheter in terms of diam-
eter, size, flexibility, and ablation protocol. The second phase
was based on an in vivo porcine model and assessed the
safety and feasibility of the novel technique with a 30-day
follow-up. In both phases the electrodes were powered by a
Radionics Cosman Coagulator CC-1 (Radionics, Burlington,
MA, USA), a versatile generator previously used with endo-
vascular RF catheters for arterial occlusion in liver cancer [8].
Impedance evolution was recorded during the ablations by a
USB data acquisition module connected to the RF generator.
2.1. Tissue samples for ex vivo and in vivo models
The in vivo study was conducted on 8 Landrace-Large White
pigs (27.3 kg mean weight), according to the protocol
approved by Ethical Commission of the Universitat
Autonoma de Barcelona (Authorization Number CEEAH 3487
and DMAH 9583) and the Government of Catalonia’s Animal
Care Committee. The ex vivo study was conducted on two
types of sample: bovine liver acquired from a local slaughter-
house, and porcine pancreas obtained from 3 pigs, which
underwent necropsy under the same authorized protocol as
that used in the in vivo study.
2.2. Considerations on the catheter design
In general, successful endoluminal ablation should ensure:
(1) catheter flexibility to operate inside the duct, (2) shallow
thermal lesions circumscribed exclusively to the tissue
around the pancreatic duct (sufficient to completely seal the
secondary ducts draining into the main duct), and (3) the
ability to estimate a suitable level of applied voltage from
the initial impedance measurement. Potential catheter
designs for endoluminal ablation should also take the follow-
ing issues into account: number of electrodes (single or mul-
tiple), function mode (mono-, bi-, multi-polar), electrode type
(dry or wet), and application procedure (point-to-point or
continuous pullback).
The first tentative test was on a single long RF electrode
based on a 3 Fr metallic guide whose length was tailored to
the lesion length in order to create one long lesion by
‘segmental’ ablation. This first idea was discarded since the
edge effect prevented the formation of a long uniform ther-
mal lesion around one RF electrode. Regardless of the abla-
tion time (10–20 s), the lesion surrounding the electrode was
nonhomogeneous and much deeper at the edges, which
was associated with overheating, audible steam pops (regis-
tered at 2–4 s) and tissue sticking. Also, the long metal wire
was not sufficiently flexible to operate inside soft delicate tis-
sue. Another consideration was that a single long RF elec-
trode must be operated in monopolar mode, making it
difficult to predict the thermal lesion geometry, since the
exact power delivered to the target site depends on the
unpredictable electrical characteristics of all the tissues
involved in the electrical circuit.
The bipolar mode employs at least two closely spaced
electrodes to create shallow thermal lesions confined to the
inter-electrode space. The applied power depends almost
exclusively on the characteristics of the tissue between the
electrodes. Less power is required in bipolar mode to ablate
the same lesion volume, which is appropriate in terms of
safety, especially when working on small or fragile organs,
such as the pancreas, which is surrounded by other deli-
cate organs.
A final issue to be considered is the possible internal cool-
ing of the electrodes. Although cooled electrodes have an
advantage over dry electrodes and avoid tissue sticking (e.g.
CelonProSurge Applicator, Olympus, Germany), they are also
known to create deeper thermal lesions than the dry type.
As the goal in endoluminal ablation is to create relatively
shallow thermal lesions around the pancreatic duct (1–2mm
depth) and avoid damage to the pancreatic parenchyma or
adjacent organs, dry electrodes seem to be the bet-
ter choice.
For all the procedures we employed commercially avail-
able flexible catheters, which include a pair of metal electro-
des separated by plastic insulation. The catheter would be
introduced into the pancreatic duct through the papilla and
would create thermal lesions around the electrodes, as illus-
trated in Figure 1. The lesions could be created either point-
to-point (i.e. positioning the catheter at one point and then
repositioning it to a contiguous point after having created a
lesion) or continuously by the pullback technique.
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2.3. Protocol for ex vivo experiments
Three sets of ex vivo ablations were conducted, two on
bovine liver and one on pancreatic tissue. Bovine liver was
selected for its accessibility, homogeneity, and the ease of
identifying the shape of the thermal lesions.
The first set of ex vivo ablations on liver was performed
without pullback in order to tentatively establishing the rela-
tionship between the applied power, duration and created
thermal lesion. This also allowed us to determine the
approximate potential starting point for pullback, i.e., when
the catheter pullback should start to avoid overheating and
roll-off (abrupt rise in impedance). The applied voltage was
50 V and the ablation durations varied according to the roll-
off time.
The second set of liver ablations was conducted with
catheter pullback and provided information on the relation
between pullback speed and lesion continuity. Both the first
and second sets were conducted with the catheter between
two fragments of liver (sandwich structure). The pullback
sequence was guided by the impedance progress as follows:
catheter pullback only started when impedance reached a
plateau (ensuring sufficient heating of the tissue in contact
with the electrodes) and with early signs of an imminent cut-
out, i.e. when the impedance attempted to rise (implying
overheating). In other words, the goal was to keep the
impedance as steady as possible, since it is reasonable to
assume that this implies that the same amount of power is
being applied along the entire duct, hence ensuring the con-
tinuity of the thermal lesion without the need for overlap-
ping. Pullback was carried out manually by the operator,
who moved the catheter according to impedance progress
as reflected in an audible signal provided by the RF gener-
ator. In this second set of ex vivo ablations the applied volt-
age was slightly lower (43 V instead of 50 V), since
preliminary trials had shown that better pullback control
could be obtained at this value. The liver ablations were con-
ducted with a 5 Fr catheter as used in cardiac electrophysi-
ology (see Figure 1(C)). Their durations varied with the
length of the liver fragment.
Once the impedance-guided procedure was seen to be
feasible, a third set of ablations was conducted on porcine
pancreas. Sample size in this set was small (n¼ 3) due to a
limited supply of ex vivo pancreatic specimens. Since it was
not possible to introduce a 5 Fr catheter into the porcine
duct, this set was finally conducted by a 3 Fr catheter
(Minitrode, Bioampere Research, Conselve, Italy) with two 3
and 4mm long 10mm interspaced electrodes (Figure 1(D)).
In this case the applied voltage was also 43 V, which implied
a power of 5W.
2.4. Protocol for in vivo experiments
The ablation protocol established in the ex vivo trials was
then tested on 8 Landrace-Large White pigs. This sample size
was used in a previous study with a similar objective [7].
Prior to surgery, all the animals underwent a 12 h-fast. All
were premedicated with azaperone (4mg/kg intramuscularly
(IM)) (StresnilVR , Ecuphar veterinaria, Spain), ketamine (10mg/
kg IM) (KetamidorVR , Richter Pharma, Austria) and morphine
(0.2mg/kg IM) (Morfina B.BraunVR , B.Braun Medical, Spain).
Figure 1. (A) Overview of the catheter-based technique for endoluminal radiofrequency sealing of pancreatic duct. The catheter is introduced into the pancreatic
duct through the papilla. (B) Detail of catheter tip in which RF power is applied between two electrodes. The thermal lesion causes the duct to seal (the illustration
is that of a human pancreas). (C) 5 Fr bipolar RF catheter used for ex vivo ablations on bovine liver (the most proximal electrodes were used for ablations). (D) 3 Fr
bipolar RF catheter used for ex vivo and in vivo ablations on porcine pancreas.
INTERNATIONAL JOURNAL OF HYPERTHERMIA 679
Induction was performed with propofol 2–4mg kg1 intra-
venously (IV) (Propofol lipuroVR , B.Braun Vetcare, Spain). After
induction, all the animals were intubated with an orotracheal
tube, and anesthesia was continued during the surgical pro-
cedure with isoflurane 2% (IsovetVR , Piramal Critical Care
Limited, UK) in 100% oxygen through a rebreathing circuit.
Lactated Ringer’s solution was infused at a rate of 10ml/kg/h
during the peri-operative period. Antibiotic therapy was
administered with cephazoline 20mg/kg IV (cefazolina
normonVR , Laboratorios Normon, Spain) via the cephalic vein.
Heart rate, respiratory rate, pulse oximetry, electrocardiog-
raphy, noninvasive blood pressure and capnography were
monitored during anesthesia using a multi-parameter moni-
tor (VetCareVR , B Braun Vetcare, Spain).
Thermal ablations were performed with the same 3 Fr
catheter as used on the ex vivo pancreas introduced into the
duct through the pancreatic papilla by means of laparotomy
and enterotomy. Once the catheter was placed in the end
duct (10 cm insertion depth), RF power (37 V) was applied.
As in the ex vivo experiments, the catheter was pulled back
along the entire duct until one of the electrodes was no lon-
ger inside it (RF generator automatically shut down). To con-
trol the pullback speed, the operator continuously monitored
impedance visually on a laptop and by following the audible
signal emitted by the RF generator.
After this process, enterotomy and laparotomy were
closed in the conventional manner. The animals were kept
alive for a 30-day follow-up, after which all were again anes-
thetized, intubated and ventilated for laparotomy and dissec-
tion of the entire pancreas, which was then immediately
placed in 10% buffered neutral formalin. The animals were
then euthanized using a commercial euthanasia solution. The
principal duct of the dissected pancreas was identified and
cannulated and the following tests were conducted: a feasi-
bility test, consisting of reintroducing the catheter into the
pancreatic duct through the duodenal papilla, and a perme-
ability loss test consisting of injecting saline into the ablated
duct. The pancreas was divided into 3mm–thick sections for
further histological analysis and 2 or 3 5 mm samples from
each section were stained with hematoxylin and eosin and
then evaluated by light microscopy. Pathologists unaware of
the experimental design assigned the degree of exocrine
pancreas atrophy from 0 to 5.
All the surgical procedures were performed by the same
surgical team (AA and XM). To analyze sealing effectiveness,
alterations of the animals’ weight increments at 30 days after
surgery, feasibility of reintroducing the catheter into the pan-
creatic duct, and duct permeability were considered. The
degree of atrophy was determined by histological analysis.
3. Results
3.1. Ex vivo experiments
In the first set of ex vivo ablations on bovine liver (without
pullback) initial impedance was 606 ± 14 X, and the mean
applied power was 5W (50 V applied voltage). In all the
ablations we observed a similar impedance pattern, which
went through the following consecutive phases: 1) gradual
initial impedance drop toward a steady minimum value, 2)
plateau phase with a fairly steady minimum value, and 3)
abrupt impedance rise. The beginning of the plateau phase
occurred at 12 ± 3 s and coincided with the start of visible
and audible signs of tissue overheating, such as steam pops,
and also with a visible thermal lesion (tissue whitening).
Impedance during the plateau was 384 ± 20 X. The abrupt
impedance rise occurred at 21 ± 6 s and was preceded by
audible pops 5 s before ablation ended.
The second set of ex vivo ablations employed the pull-
back technique and an attempt to keep a constant imped-
ance value as long as possible, which meant keeping the
plateau for as long as possible. The applied voltage was
reduced to 43 V, since 50 V led to rapid tissue overheating,
electrode sticking and a non-uniform lesion. As in the first
set, the initial impedance and plateau impedance were
568 ± 48X and 334 ± 37X, respectively. In this case, due to
the voltage reduction, applied power was 5W. In this
second set we identified two main factors associated with
pullback that affected lesion geometry and size: speed
(slow vs. fast) and continuity (intermittent vs. uninterrupted
–continuous–). A fast and continuous pullback caused an ini-
tial minor impedance drop and led to greater number of
abrupt impedance rises, although without visible lesions.
When pullback was slow, two different types of behavior
were seen that depended on pullback continuity:
1. When pullback was slow and intermittent, impedance
followed a sawtooth waveform with small abrupt rises
(see black arrow in Figure 2(A)) each time the catheter
was moved, so that the evolution matched well with the
lesion pattern. The intermittency involved tissue charring
and sticking just before the end of pullback, or at
extremely low speed, while gaps appeared (absence of
thermal lesion) with a fast pullback.
2. When pullback was slow and continuous, the impedance
waveform smoothed out (see Figure 2(B)) and avoided
tissue sticking. The lesions thus produced were also uni-
form in depth, with a whitish zone extending continu-
ously 1mm around the electrode along the entire
ablation line (see Figure 2(D)). In these cases the plateau
was reached in 23 s, after which pullback was applied
at a mean speed of 0.07 cm/s. When the speed
became too slow, impedance gradually rose (black arrow
in Figure 2(C)), which was interpreted as an early sign of
an imminent impedance jump (implying overheating)
and therefore pullback was speeded up.
The third set of ex vivo ablations was conducted on pan-
creatic tissue with a 3 Fr instead of a 5 Fr catheter, since the
pancreatic lumen was narrower than expected. The initial
impedance was 523 ± 29X, a value slightly lower than that
obtained by a 5 Fr catheter on bovine liver. The applied volt-
age was kept at the same level as in the previous set
(43 V). Impedance followed the three-phase pattern
observed in the first two sets of ex vivo ablations. The time
to reach plateau was more than 100 s, which was three times
longer than in the two previous sets. The impedance value
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at the plateau was 302 ± 40X (see Figure 3(A)). Abrupt
impedance increases were associated with tissue sticking and
carbonization points (see black arrow in Figure 3(B)), just
after which the catheter was relocated. Unfortunately, this
movement caused visible gaps (see white arrow in Figure
3(B)), since they were associated exactly with the zones
where the electrodes did not apply power as the catheter
was moved. As in the previous sets, we also observed that
pulling back too fast impeded the creation of visible thermal
lesions. Overall, the lesions created in this third set showed
larger margins (2–3mm) than the two previous sets on liver
with a 5 Fr catheter. During the ablations, more abrupt
impedance changes and more roll-offs occurred, which
contributed to a more intermittent pullback and to irregular
lesions in terms of depth and continuity (i.e. with gaps).
3.2. In vivo experiments
Since the tissue lesions of the in vivo group could not be
seen until 30 days after the procedure, the evolution of the
electrical variables was the only indicator for creating uni-
form and continuous thermal lesions. The mean initial
impedance was 308 ± 60X, considerably lower than in the ex
vivo specimens. The applied voltage was reduced to 37 V,
which implied a power of 5W (comparable to the value
measured in ex vivo ablations). A time of 30 s was required
Figure 2. Results of the second set of ex vivo experiments. (A–C) Examples of impedance evolution (A). Small-amplitude sawtooth associated with slow and inter-
mittent catheter pullback; (B and C). Smooth patterns associated with slow and continuous catheter pullback. (D) Thermal lesion created on bovine liver by slow
and continuous pullback (impedance shown in B).
Figure 3. Results of the third set of ex vivo experiments. (A) Typical impedance during ablation. (B) Lesion created along the pancreatic duct in a pancreas treated
with 43 V and pullback as continuous as possible. Gray bands show power cut off instants after abrupt impedance increases associated with tissue sticking and car-
bonization (black arrow in B). After this event pullback was always speeded up in order to relocate the catheter, which in turn led to some visible gaps (white
arrow in B).
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to reach the impedance plateau (220 ± 35X), at which time
pullback started. Impedance followed the same three-phase
pattern as in the ex vivo ablations. However, the in vivo abla-
tions showed a higher incidence of roll-offs, estimated as
one every 40 s of ablation, and the impedance rises usually
involved tissue sticking, which forced us to relocate the cath-
eter rapidly in order to complete the ablation, which often
required vigorous action. This meant the impedance evolu-
tion was more irregular than in the ex vivo experiments.
Total ablation duration varied slightly in the trials in relation
to specific duct length and roll-off occurrence. An average of
11 cm of pancreatic duct was ablated at a mean pullback
speed of 0.1 cm/s.
During the 30-day follow-up the animals experienced
alterations of stool consistency. After this period, their mean
weight was 31 kg, which meant a slower than normal rate of
weight gain (4 kg per 30 days). At necropsy, the feasibility
test to verify the presence of ductal occlusion failed, since it
was impossible to re-insert more than a few centimeters of
the catheter into the duct, due to the lumen being too nar-
row. This also meant we could not perform the permeability
test, as the liquid could not be injected as planned through
the distal end of the duct. All this suggested that sealing
was completely effective after 30 days at the level of the
duodenal papilla. Beyond the papilla, a macroscopic view of
cross-sections of pancreatic duct revealed different degrees
of ductal dilation (diameter ranging widely from <1mm to
>10mm), although at the level of the head the lumen
seemed completely sealed in all cases (Section A in Figure 4).
Figure 5 shows histological images of normal pancreatic
tissue and pancreas after treatment. The histological study of
the treated samples revealed complete acinar atrophy and
that only the intralobular ducts remained after ductal abla-
tion (Figure 5(D,E)). The epithelium of the interlobular and
some of the intralobular ducts showed a metaplasia from
columnar or cuboidal to squamous and was lost in other
areas (Figure 5(F)). All the samples showed marked periductal
and interlobular fibrosis (Figure 5(D–F)) and scattered inflam-
matory infiltrate (Figure 5(F)).
4. Discussion
Sealing the pancreatic duct has always been challenging due
to the risk of pancreatic juice leaking into the peritoneal cav-
ity, which continues to be the main complication contribu-
ting to the high mortality rate [7]. The endoluminal RFA with
pullback proposed here could potentially reduce this risk.
Moreover, being a minimally-invasive technique, it offers the
advantages of a likely faster recovery and fewer side effects
than injecting a sealing agent or tissue suturing. To our
knowledge, this is the first study to examine the feasibility of
the catheter-based RF sealing technique for the pancreatic
duct. As this was a development study, it had several phases
to progressively fine-tune the proposed technique (catheter
and ablation protocol) and finally obtain relevant information
on its safety and performance on an in vivo porcine model.
4.1. Initial steps fine-tuning technique
The first phases conducted on liver ex vivo fragments
showed how the different variables involved interact with
each other during ablation with pullback. What we learned
Figure 4. Results of the in vivo experiments. Macroscopic images of one of the treated pancreas and cross sections at the level of the head (A) and body (B). Red
circles indicate the position of the main duct. Lumen was not completely closed in all cases and ductal dilation was observed, particularly in the body (units in cm).
Gray dashed line indicates the main duct position in pancreas.
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was that: (1) a few watts (5W) are enough to create
1–2mm deep lesions; (2) pullback must begin when the
impedance plateau is reached, which may coincide with aud-
ible pops; (3) it is possible to modulate the rate of pullback
to keep the impedance as steady as possible, i.e. to try to
maintain the plateau phase during the entire procedure; (4)
this can be done by monitoring impedance and/or by an
audible signal associated with impedance progress; and (5) if
all these conditions are observed, the thermal lesion can be
continuous (without gaps) along the entire path.
When we tried to transfer these conditions to the case of
the pancreatic duct (pancreas ex vivo ablations), we learned
that: (1) a narrower catheter diameter is required (3 Fr
instead of 5 Fr); (2) catheter pullback through the pancreatic
duct is less straightforward than the simple movement
between two slices of liver tissue; (3) this means that the
impedance-guided lesion is not so effective in the pancreas,
with sticking, a need for overlap, and possible gaps; (4) sud-
den impedance rises are possibly related to tissue sticking
and require moving the catheter, with the possibility of gaps;
(5) gaps can be also produced by excessive pullback speed;
and (6) when present, thermal lesions are 2–3mm deep. This
information was used to carry out a 30-day survival in
vivo study.
4.2. Clinical assessment of the technique
On planning the in vivo study we expected thermal ablation
inside the pancreatic main duct to produce the following
phenomena: (1) occlusion of the small exocrine ducts
branching from the main duct and subsequent acinar atro-
phy, causing the suppression of exocrine secretions; and (2)
shrinkage of the collagen fibers around the main duct and
subsequent reduction of its lumen, making it less permeable.
Initially we thought that in order for these phenomena to
occur efficiently, a continuous thermal lesion had to be cre-
ated along a segment of the main duct. This was probably
over-optimistic, since although thermal ablation produces
immediate tissue shrinkage (due to protein denaturation and
collagen contraction) this could only create a partial occlu-
sion, as opposed to other mechanical methods (such as
suture or stapler).
What the in vivo study revealed is that it is very difficult
to create continuous lesions along the pancreatic duct, pos-
sibly due to the irregular anatomy of the main duct, but also
due to the technical limitations of the impedance-guided
protocol. In fact, gaps were observed in the ex vivo pancreas
just after ablation. In the same way, the sudden impedance
rises during in vivo ablations suggest the possible presence
of gaps in the lesion and the possibility of the diameter not
being reduced along the whole ablation length. This was
later confirmed in the macroscopic analysis, where the main
duct was not completely occluded in all zones. Complete
duct occlusion at the pancreas head was also evident from
the impossibility of reinserting the catheter through the duo-
denal papilla. We still do not have a convincing explanation
of why the proximal duct (head zone) was more occluded
than the distal duct. The images in Figure 4 also show that
the ablated duct was usually circular in shape, regardless of
the dilation diameter or location, which suggests that the
energy deposition occurred symmetrically around the elec-
trodes and was limited in depth.
Interestingly, despite the existence of lesion gaps and
presence of non-occluded segments, clinical observations
during follow-up and histological findings were compatible
Figure 5. Results of in vivo experiment. Histological images of normal pancreas (A, B, C) and samples with sealing-induced pancreatic atrophy (D, E, F). Compared
to normal pancreatic tissue, the treated samples show evident atrophy of the acinar component (purple dye) with only intralobular ducts remaining (D, E); the epi-
thelium of the interlobular ducts is flattened or has been lost (F, black arrow); marked interlobular fibrosis (D, E; F); scattered inflammatory infiltrate (E, F). H&E 5
(A, D) and 20 (B, C, E, F).
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with complete exocrine atrophy. The atrophic pancreas was
deprived of acini to secrete digestive enzymes, which caused
the failure of the digestive functions. All the animals experi-
enced digestive alterations and a notably reduced rate of
weight gain after the 30-day follow-up.
In view of all the results, the complete occlusion of the
entire main duct may not be required to generate complete
exocrine atrophy. In fact, it is possible that the partially
occluded duct segments also contributed to the exocrine
atrophy. Since RF ablation also severs duct walls and produ-
ces thermal necrosis and apoptosis of the ablated zone, it is
likely that atrophy and acinar cell loss are also a result of
thermally-induced apoptosis. It is thus reasonable to assume
that a fully continuous lesion along the main duct might not
be necessary to achieve exocrine atrophy, which would be
triggered not only by an immediate RF-induced effect, but
also by biological processes within 30 days after ablation.
4.3. Safety issues
Regarding the safety issues involved in the ablative tech-
nique, we must keep in mind that bipolar RFA has already
been clinically used for endoluminal ablation of vessels and
biliary duct, so the concept of endoluminal ablation itself is
well-known and assumed to be safe. The risks of using RFA
instead of another mechanical method, such as staplers,
sutures or clips, could include overheating of the target tis-
sue and unintentional ablation of the neighboring tissue
(e.g. intestine). In our study these risks were minimized by
establishing a ‘safe ablation environment’ by trying to keep
the pancreas as far as possible from other viscera during
ablation by simple mechanical deviation. In addition, all the
procedures were accomplished by personnel experienced in
using RF-based devices. Finally, the absence of postoperative
complications associated with RF power suggests that the
proposed ablation method keeps risks at a reasonably
low level.
4.4. Technical feasibility
The ablation control proposed in this study is entirely based
on impedance progress. We discarded temperature monitor-
ing due to it being technically complex to include tempera-
ture sensors in such a small catheter. Moreover, while a
temperature sensor would only provide information on the
temperature in the tissue in contact with it (not necessarily
the maximum tissue temperature), impedance gives a more
complete picture of the characteristics of tissue affected by
ablation through the direct relationship between electrical
conductivity and temperature. In fact, this technique has
been used previously in the management of biliary tumors
and venous obstruction or other venous insufficiencies
[10–13]. While we designed our own endoluminal RFA proto-
col, other studies used commercial devices designed for
treating varicose veins (e.g. Celon ProCurve, Olympus,
Germany). In both cases the method is based on impedance
feedback for catheter guidance by visualizing impedance
and power evolution and attending to audible signals. It also
allows working in a specific impedance range that cuts out
when exceeded. We had to adapt this technique to the pre-
sent study, since endoluminal RFA had never been used
before to seal the pancreatic duct. The delicate pancreatic
tissue structure required a flexible applicator and the right
catheter to fit a 1mm duct diameter, which ruled out the
use of the commercial product of 5 Fr.
In addition, impedance monitoring has already been pro-
posed to estimate the temperature and lesion size during RF
ablation due to the inverse relationship of both parameters
[14]. Tissue heating enhances ion mobility and current flow
and thus produces a characteristic impedance drop in the
early stages of ablation. Although thermal lesions in high-
temperature ablative techniques require temperatures in the
range 50–100 C, it is also known that lesion evolution is
closely connected to the temperature-time relationship,
which depends on the amount of power applied. In particu-
lar, it is known that a few minutes of exposure at 50 C trig-
gers progressive tissue shrinkage and irreversible tissue
damage [15], while only a few seconds at 60 C produce tis-
sue coagulative necrosis seen as a whitish area in the abla-
tion zone [16,17]. Once thermal equilibrium has been
reached, the impedance value stabilizes at the minimum and
lesion size remains static. Further ablation leads to tissue
overheating and vaporization at temperatures between 100
and 105 C and is characterized by audible steam pops, an
abrupt impedance rise, tissue carbonization and sticking [17].
Once focused on impedance monitoring, our findings identi-
fied three different phases in its progress during ablation: 1)
a drop associated with initial heating, 2) a plateau phase,
and 3) occasional abrupt increases associated with overheat-
ing. All the phases could easily be distinguished in our ex
vivo findings, in which whitish and carbonization zones
appeared, suggesting that the tissue was in fact exposed to
the 60–100 C range. Overheating incidents also occurred in
the in vivo study and suggest that the tissue was exposed to
temperatures of up to 100 C. The longer the plateau phase,
the longer the ablation with sufficient power delivery and
without carbonization. It has also been suggested that keep-
ing the plateau impedance at a target value for a specific
time should lead to the desired lesion depth [9]. The value
of the plateau phase depends on tissue type and other con-
ditions that affect its electrical properties, such as hydration
or blood irrigation [18,19]. For instance, in our study the dif-
ferences between the ex vivo and in vivo models were pos-
sibly related to additional heat loss by convective blood
perfusion cooling (also known as heat sink effect), which is
only present under in vivo conditions. Other factors could
also have affected these differences, such as a smaller
impedance drop and a higher threshold temperature for
coagulative necrosis, finally producing smaller lesion depths
in the in vivo case. Accordingly, we observed that in vivo
samples had nearly half as low initial impedance values
(308 ± 60X vs 523 ± 29X) and a smaller impedance drop
(220 ± 35X vs 302 ± 40X at plateau) than ex vivo specimens.
We were not able to assess the differences in lesion depth
between ex vivo and in vivo cases since in the latter case the
lesion dimensions were assessed after a 30-day follow-up
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period. However, our findings can be discussed in the light
of previous liver studies (with a similar pancreas blood perfu-
sion rate, 860 ± 170ml/min/kg vs. 767 ± 357ml/min/kg [20]).
These studies showed that in vivo lesions have a 36–44%
smaller diameter than ex vivo lesions [21–23], which sug-
gests that the in vivo pancreatic lesions created in our study
could be around 1mm deep (since lesion depth was 2–3mm
in the ex vivo case and similar power levels were used in
both cases).
Additionally, different studies have reported that tissue
shrinkage (which starts at 50 C) produces up to 20–30% of
tissue constriction of the initial margin and therefore the real
ablation zone is actually greater than that measured
[15,24,25], while a limited degree of tissue shrinkage could
also reduce the chances of complete mechanical occlusion of
the duct, although, as seen in our study, it was sufficient to
reduce the duct diameter to less than the catheter diameter
and ruled out catheter reintroduction.
Due to variations in the electrical properties of ex and in
vivo tissue, a lower voltage value was used in the in vivo
study (43 V vs. 38 V). This change also affected the pullback
speed (0.03 cm/s vs. 0.1 cm/s), but in all cases a power of
5W could be delivered, suggesting that the delivered
power, as determined by applied voltage and pullback
speed, is the vital parameter in achieving successful RFA. The
power and pullback speed values used in our study were
noticeably lower than those usually reported for venous
ablation (18–25W and 0.5–1 cm/s, respectively)
[9,12,13,26,27]. Numerous studies have reported that the rec-
ommended clinical power and pullback speed values can
increase the incidence of tissue carbonization and sticking
[12]. An additional issue in obtaining permanent sealing is
the need to reapply the treatment (overlapping) to provide
sufficient energy for effective sealing [28]. Interestingly,
Badham et al. [12] suggested that values of 6W and 0.08 cm/
s are the most optimal to obtain a successful vein lesion by
single RF ablation and avoid tissue overheating and sticking.
These values are very similar to these employed by us (5W,
0.03–0.1 cm/s). It is important to note that while we aimed
for a slow continuous pullback, Badham et al. used a discon-
tinuous pullback, so that 0.08 cm/s was really an approximate
value. This similarity could be owing to the electrical proper-
ties of both tissues. In the in vivo study we found that a
large number of abrupt impedance increases and tissue
sticking events were inevitable. This problem could pose a
serious risk of soft tissue rupture during the treatment. The
relationship between the applied power and pullback speed
determines the required energy level and the rate at which
it is delivered to the tissue, and thus the final thermal dose
to cause tissue damage. The optimization of these parame-
ters is still pending.
The outcomes obtained from this technique are undoubt-
edly affected by the additional factor of the operator’s skill
in controlling catheter pullback [26]. As already mentioned,
an excessively slow pullback implies greater power deposited
in the target area together with carbonization and sticking,
while an exceedingly fast pullback produces gaps or even no
lesion at all. Although the manufacturers usually recommend
the appropriate powers and speeds to obtain continuous
lesions and avoid overheating, the inherent tissue heterogen-
eity impedes creating a uniform lesion along the entire path.
The operator’s skill thus plays a vital role in varying pullback
speed according to the impedance variations encountered.
The amount of delivered power and pullback speed will also
vary according to the desired outcome and may differ from
the manufacturer’s recommendations [27,28]. For all these
reasons it is important to first estimate the relationship
between impedance, delivered power and the required ther-
mal lesion before applying endoluminal RFA with pullback.
4.5. Limitations of the study
Although our final clinical objective is the management of
the pancreatic stump, the in vivo study was conducted on a
non-transected pancreatic duct. A transected pancreas model
would be more complex and would entail a higher risk of
pancreatic leakage. Further research on this matter should
therefore be conducted involving endoluminal RF sealing of
the transected pancreatic duct in order to confirm the feasi-
bility of the technique on a more realistic model.
As regards the clinical implications, it is important to note
that the porcine model used in this study is anatomically dif-
ferent to the human pancreas in certain respects, as it has a
secondary duct branching out from the main pancreatic duct
(see Figure 1 from [7]). In our study this duct was not
ablated and therefore maintained its enzymatic secretory
function, which could have reduced the effectiveness of the
proposed technique. For this very reason, the technique
could be even more effective in the human pancreas.
5. Conclusions
The impedance-guided endoluminal RFA technique designed
to seal the pancreatic duct seems to be a promising, feasible
and safe alternative for management of the pancreatic stump
and reducing the risk of leakage. Although power and pull-
back speed still need to be optimized, the findings obtained
suggest that a fully continuous RFA lesion along the entire
duct may not in fact be required to achieve pancre-
atic atrophy.
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